I thought I would double check with some more searches and found more FDA granted Orphan Drug Designations in 2010.
A good one is the recently granted drug Epitalon from ASX listed company BioDiem (BDM) on 09 Sept 2010.
See announcement, http://www.asx.net.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01096692
Another is Ciprofloxacin from Bayer in Feb 2010,
See link, http://www.pharma.bayer.com/scripts/pages/en/news_room/news_room/news_room88.php
One more is BMN-701 from BioMarin in Aug 2010,
See link, http://www.pharmpro.com/news/2010/08/agencies-and-organizations-BioMarin-Receives-Orphan-Drug-Designation/
When I searched for these drugs on the FDA website they all showed 'Not FDA Approved for Orphan Indication'.
Of particular notice is the paragraph from the second article for Ciprofloxacin from Bayer, it says -
About Orphan Drug Designation in the United States
Under legislation passed by the U.S. Congress in 1983, the Orphan Drugs Act provides incentives to sponsors to develop products for rare diseases. The first sponsor who obtains marketing approval for a designated orphan drug or biological product is granted US market exclusivity for a seven-year period. Exclusivity begins on the date that the marketing application is approved by the FDA for the designated orphan drug and applies only to the indication for which the drug has been designated and approved. The approval of an orphan designation request does not alter the standard regulatory requirements and process for obtaining marketing approval. Safety and efficacy of a compound must be established through adequate and well-controlled studies.
After completing this quick extra research on what 'Orphan Drug Designation - Designated' means on the FDA site, I'm pretty sure that Prima has got ODS for CVAC.
I could be wrong, so until we get something official from the Prima take these post as just my thoughts on the matter.
Again thanks Loosecash for find this out.
- Forums
- ASX - By Stock
- IMM
- fda ods approved
fda ods approved, page-17
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
0.010(2.99%) |
Mkt cap ! $501.1M |
Open | High | Low | Value | Volume |
34.0¢ | 34.5¢ | 32.8¢ | $567.5K | 1.672M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 64827 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 316094 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 64827 | 0.340 |
14 | 95667 | 0.335 |
12 | 141554 | 0.330 |
10 | 115864 | 0.325 |
11 | 135909 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 316094 | 23 |
0.350 | 267922 | 15 |
0.355 | 158816 | 14 |
0.360 | 333941 | 10 |
0.365 | 212160 | 9 |
Last trade - 13.56pm 15/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online